By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel's net takeaway is that while ISCV offers a lower expense ratio and recent outperformance, its higher liquidity risk, mean reversion potential, and sensitivity to rate spikes and domestic slowdowns make it a riskier choice compared to IJJ. The panel is concerned about ISCV's deeper drawdown, smaller AUM, and higher turnover, which could lead to tracking error and tax drag in stressed markets.
Risk: Liquidity risk and potential tracking error in stressed markets due to ISCV's smaller AUM and higher turnover.
Opportunity: ISCV's 12bp fee advantage and broader holdings could compound faster than IJJ's liquidity premium if the Fed pivots and interest rates ease.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
iShares Morningstar Small-Cap Value ETF offers a significantly lower expense ratio than iShares S&P Mid-Cap 400 Value ETF.
iShares Morningstar Small-Cap Value ETF has outperformed on a one-year total return basis but has also experienced a deeper maximum drawdown.
iShares Morningstar Small-Cap Value ETF provides broader diversification across more than 1,000 holdings compared to the mid-cap focus of iShares S&P Mid-Cap 400 Value ETF.
iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) provides lower-cost access to small-cap value stocks, while iShares S&P Mid-Cap 400 Value ETF (NYSEMKT:IJJ) offers exposure to larger, mid-capitalization companies.
Investors seeking value-oriented equities often weigh the trade-offs between mid-cap and small-cap segments. While IJJ targets the middle of the market, ISCV focuses on smaller companies. Both funds utilize value screens but differ significantly in their expense ratios, market capitalization focus, and total assets under management (AUM).
| Metric | IJJ | ISCV | |---|---|---| | Issuer | iShares | iShares | | Expense ratio | 0.18% | 0.06% | | 1-yr return (as of May 18, 2026) | 22.25% | 30.94% | | Dividend yield | 1.70% | 1.90% | | Beta | 0.97 | 1.00 | | AUM | $8.3 billion | $640.0 million |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The one-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
With an expense ratio of 0.06%, the iShares Morningstar Small-Cap Value ETF is notably more affordable than the 0.18% charged by the iShares S&P Mid-Cap 400 Value ETF. The small-cap fund also currently provides a slightly higher yield for income-focused investors.
| Metric | IJJ | ISCV | |---|---|---| | Max drawdown (5 yr) | (22.70%) | (25.30%) | | Growth of $1,000 over five years (total return) | $1,420 | $1,387 |
The iShares Morningstar Small-Cap Value ETF has delivered higher one-year total returns but also experienced a deeper maximum drawdown over the five-year period, reflecting the typical volatility associated with smaller companies. Over a longer five-year horizon, the mid-cap focus of the iShares S&P Mid-Cap 400 Value ETF has resulted in a slightly higher growth of a $1,000 investment.
The iShares Morningstar Small-Cap Value ETF, launched in 2004, manages a broad portfolio of 1,069 holdings. Its sector allocation is led by financial services at 21.00%, consumer cyclical at 13.00%, and industrials at 13.00%. Its largest positions include Akamai Technologies (NASDAQ:AKAM) at 0.70%, CF Industries (NYSE:CF) at 0.65%, and Viatris (NASDAQ:VTRS) at 0.63%. Over the trailing 12 months, the fund paid $1.41 per share in dividends.
In contrast, the iShares S&P Mid-Cap 400 Value ETF was launched in 2000 and holds 305 positions. It is similarly concentrated in financial services at 22.00%, industrials at 19.00%, and consumer cyclical at 13.00%. Top holdings include Reliance Steel & Aluminum (NYSE:RS) at 1.16%, US Foods (NYSE:USFD) at 1.11%, and Wesco International (NYSE:WCC) at 1.07%. It has a trailing-12-month dividend of $2.34 per share.
For more guidance on ETF investing, check out the full guide at this link.
Small-cap and mid-cap stocks both sit outside the S&P 500's spotlight, but they behave quite differently. Small-cap companies are earlier in their growth journey, more sensitive to domestic economic shifts, and capable of sharper gains and losses. Mid-cap companies have generally proven their business models and tend to offer a steadier ride, sitting between the volatility of small caps and the predictability of large caps. Both tiers have historically rewarded patient value investors over long time horizons.
ISCV outpaced IJJ over the past year, reflecting a period when small-cap value stocks benefited from optimism around domestic economic growth and deregulation. That kind of outperformance is typical of small caps in risk-on environments, but the gap can reverse quickly when uncertainty rises and investors gravitate toward the relative safety of larger companies.
ISCV also charges significantly less than IJJ, a meaningful advantage for long-term holders. It’s also the more enticing choice for aggressive investors willing to accept more volatility for greater growth potential. IJJ's much larger asset base and longer track record give it an edge in liquidity and institutional credibility, making it the more measured option for those who want value exposure with a smoother long-term experience.
Before you buy stock in iShares Trust - iShares Morningstar Small-Cap Value ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap Value ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $472,852! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,317,207!
Now, it’s worth noting Stock Advisor’s total average return is 984% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 27, 2026. *
Sara Appino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Wesco International. The Motley Fool recommends Akamai Technologies. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"ISCV's liquidity and volatility disadvantages outweigh its fee and recent-return advantages relative to IJJ."
The article flags ISCV's 30.94% one-year return and 0.06% expense ratio versus IJJ, yet downplays how ISCV's 1,069 holdings and $640M AUM create material liquidity and tracking risks absent in IJJ's $8.3B, 305-stock structure. Small-cap value's typical sensitivity to rate spikes and domestic slowdowns is acknowledged but not quantified against the current macro backdrop of sticky inflation. Five-year growth favors IJJ ($1,420 vs $1,387), suggesting the recent gap may reflect a one-off risk-on window rather than a durable edge.
Small-cap value premiums have historically reasserted after mid-cap rotations, and ISCV's lower fees plus 1,000+ holdings could compound outperformance if deregulation extends the domestic growth cycle.
"ISCV's 1-year outperformance is cyclical, not structural; its 5-year underperformance and higher drawdown suggest mean reversion risk outweighs the fee advantage in a risk-off environment."
The article frames ISCV's 1-year outperformance (30.94% vs 22.25%) as cyclical and reversible, but glosses over a critical detail: ISCV's 5-year absolute return ($1,387 per $1k) actually trails IJJ ($1,420) despite lower volatility recently. The real story is mean reversion risk. Small-cap value has had a strong 12 months on deregulation/growth optimism, but the article's own data shows ISCV carries 25.3% max drawdown vs IJJ's 22.7%—and that was during a favorable regime. The 12bp fee advantage (0.06% vs 0.18%) is real but immaterial over 1-2 years if sector rotation hits. AUM disparity ($640M vs $8.3B) also signals institutional conviction favors mid-cap.
Small-cap value could continue outperforming if deregulation and domestic growth accelerate—the article's own thesis—making the fee advantage compounding over years. ISCV's broader diversification (1,069 holdings) may provide downside protection that the 5-year data hasn't yet captured.
"The expense ratio difference is a rounding error compared to the systemic liquidity and credit-cycle risks inherent in the small-cap value factor."
The article frames this as a simple choice between cost-efficiency and stability, but it misses the critical factor of interest rate sensitivity. ISCV's tilt toward small-cap value makes it a direct proxy for the health of regional banks and domestic industrial balance sheets, which are highly sensitive to the 'higher for longer' rate environment. While the 12-basis-point expense ratio advantage for ISCV is mathematically superior, it is dwarfed by the liquidity risk inherent in its $640M AUM compared to IJJ’s $8.3B. Investors are paying a premium for IJJ’s liquidity and higher-quality, mid-cap balance sheets, which are far more resilient during credit tightening cycles.
If we see a sustained period of domestic re-industrialization and lower borrowing costs, the valuation multiple expansion in the small-cap segment will likely render the liquidity and quality arguments for IJJ irrelevant.
"ISCV's cost edge and small-cap value exposure are not enough to guarantee persistence without a sustained regime tailwind and liquidity support; mean reversion and higher volatility could erase the recent outperformance."
ISCV trades at 0.06% expense versus IJJ at 0.18%, and posts a stronger 1-year total return (30.94% vs 22.25%) with a slightly higher yield. Yet the drag is real: ISCV’s five-year max drawdown is deeper (25.3% vs 22.7%), and its AUM (~$640m) implies higher liquidity risk and potential tracking error in stressed markets. The fund is far more concentrated in small caps (1,069 holdings) than IJJ (305), which can magnify idiosyncratic risk and sector tilt (notably financials and industrials). The article ignores the possibility of mean reversion, potential tax/tax-efficiency issues from turnover, and regime dependence (rate moves, domestic growth) that could reverse recent outperformance.
Counterpoint: if the domestic economy remains resilient and rates stabilize, ISCV’s small-cap value tilt could continue to outperform, aided by the cost edge and ongoing capex cycles. In other words, yesterday’s drawdown risk might be rewarded in a new regime, so neutrality could miss a continued up leg.
"Rate easing could favor ISCV more than liquidity arguments allow."
Gemini flags ISCV's rate sensitivity as a clear negative but misses how small-cap value typically leads during easing cycles, as post-2019 data showed. The AUM disparity may simply reflect lagged institutional positioning rather than durable quality edge. If the Fed pivots, ISCV's 12bp fee advantage and broader holdings could compound faster than IJJ's liquidity premium offsets.
"AUM-driven liquidity risk in ISCV is unquantified and could exceed fee savings in a single drawdown event."
Grok's easing-cycle precedent is real, but it assumes Fed pivot timing we don't have. More critically: nobody's quantified ISCV's actual tracking error during stress. Claude flagged the 25.3% max drawdown, but that's backward-looking. The real question is whether $640M AUM causes slippage during forced selling—which could dwarf the 12bp fee savings in a single down month. That's testable; let's see the bid-ask spreads and redemption data.
"The liquidity risk of ISCV is secondary to the credit quality risk of its underlying small-cap holdings in a high-rate environment."
Claude is right to focus on liquidity, but the focus on AUM as a proxy for 'quality' is flawed. ISCV’s 1,069 holdings actually provide better idiosyncratic risk dispersion than IJJ’s 305. The real risk isn't just drawdown; it's the 'value trap' inherent in small-cap financials during a credit contraction. If rates stay higher for longer, the 12bp fee advantage is irrelevant compared to the solvency risk of the smaller, lower-quality balance sheets dominating ISCV's index.
"Tax drag from higher turnover in ISCV could erase the 12bp fee edge and limit durable outperformance."
Claude's emphasis on stress-test tracking error is valid, but it misses the after-tax reality for many investors. ISCV's 1,069 holdings imply higher turnover versus IJJ, which tends to translate into capital gains distributions and tax drag in taxable accounts. Even with a 0.06% expense edge, the net after-tax return could be meaningfully worse in a regime where churn remains elevated or in a sell-off when tax lot realization dominates. This could cap the durability of the fee-led advantage.
The panel's net takeaway is that while ISCV offers a lower expense ratio and recent outperformance, its higher liquidity risk, mean reversion potential, and sensitivity to rate spikes and domestic slowdowns make it a riskier choice compared to IJJ. The panel is concerned about ISCV's deeper drawdown, smaller AUM, and higher turnover, which could lead to tracking error and tax drag in stressed markets.
ISCV's 12bp fee advantage and broader holdings could compound faster than IJJ's liquidity premium if the Fed pivots and interest rates ease.
Liquidity risk and potential tracking error in stressed markets due to ISCV's smaller AUM and higher turnover.